Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opthea Limited (CKDXF)
OTHER OTC:CKDXF
Opthea Limited (CKDXF) Stock Price & Analysis
13 Followers
CKDXF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.29 - $0.61
Previous Close$0.29
Volume130.00
Average Volume (3M)N/A
Market Cap
$296.93M
Enterprise Value$207.92M
Total Cash (Recent Filing)$89.19M
Total Debt (Recent Filing)$181.71K
Price to Earnings (P/E)-1.0
Beta-0.38
Next Earnings
Aug 29, 2024EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding662,808,634
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.86
R-Squared0.12
Alpha0.34
Financial Highlights & Ratios
Price to Book (P/B)-22.65
Price to Sales (P/S)1773.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.92K
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Opthea Limited News
PremiumCompany Announcements
Opthea Showcases Retinal Disease Therapy Advances
PremiumCompany Announcements
Opthea Advances Pivotal Trials for Eye Disease Drug
PremiumCompany Announcements
Opthea Limited Issues New Employee Incentive Securities
PremiumCompany Announcements
Opthea Limited Issues New Contractor Options
PremiumCompany Announcements
Opthea Hires New VP to Advance Retinal TherapiesOwnership Overview
0.61% Insiders
2.56% Mutual Funds
1.51% Other Institutional Investors
95.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CKDXF FAQ
What was Opthea Limited’s price range in the past 12 months?
Opthea Limited lowest stock price was $0.29 and its highest was $0.61 in the past 12 months.
What is Opthea Limited’s market cap?
Currently, no data Available
When is Opthea Limited’s upcoming earnings report date?
Opthea Limited’s upcoming earnings report date is Aug 29, 2024 which is in 105 days.
How were Opthea Limited’s earnings last quarter?
Opthea Limited released its earnings results on Feb 28, 2024. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.119 by -$0.041.
Is Opthea Limited overvalued?
According to Wall Street analysts Opthea Limited’s price is currently Overvalued.
Does Opthea Limited pay dividends?
Opthea Limited does not currently pay dividends.
What is Opthea Limited’s EPS estimate?
Opthea Limited’s EPS estimate is -$0.05.
How many shares outstanding does Opthea Limited have?
Opthea Limited has 662,808,650 shares outstanding.
What happened to Opthea Limited’s price movement after its last earnings report?
Opthea Limited reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.119. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Opthea Limited?
Currently, no hedge funds are holding shares in CKDXF
---
Opthea Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
CKDXF Sentiment 94%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.61%
12-Months-Change
Fundamentals
Return on Equity
-3383.08%
Trailing 12-Months
Asset Growth
8.11%
Trailing 12-Months
Company Description
Opthea Limited
Opthea Ltd. is engaged in the development of biological therapeutics for cancer and other serious diseases. It is a biologics drug developer building on significant intellectual property portfolio around Vascular Endothelial Growth Factor C and D angiogenic molecules and R3. The company focuses on vascular endothelial growth factors to develop truly novel therapies to extend and improve the lives of cancer sufferers. Opthea was founded on October 17, 1984 and is headquartered in South Yarra, Australia.
---
CKDXF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering CKDXF
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-7.40%
downgraded a sell rating 9 months ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -7.40% per trade.
---